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Introduction: The Rho/Rho-kinase pathway has been related to various physiological
responses of the cardiovascular system. Previous reports have suggested a signiﬁcant eﬀect of
Rho signals on the electrophysiological characteristics of the heart. We hypothesized that the
Rho/Rho-kinase system would contribute to the rapid pacing-related change of atrial eﬀective
refractory period (AERP).
Methods and Results: In 17 dogs, AERP was measured at the right atrial appendage (RAA)
and posterior left atrium (LA) before, during, and after 6-hours rapid atrial pacing at 500 bpm.
Saline control (n ¼ 5), verapamil (n ¼ 5), or fasudil (n ¼ 7) were infused throughout the
protocol. The shortening of AERP after rapid pacing was abrogated by the administration of
verapamil, as reported in previous studies. Furthermore, fasudil (Rho/Rho-kinase inhibitor)
inﬂuenced the change of AERP in a manner similar to the infusion of verapamil throughout
the experiments.
Conclusions: Since the AERP was attenuated by fasudil, rapid pacing-related atrial
electrophysiological changes might involve the Rho/Rho-kinase pathway.
(J Arrhythmia 2006; 22: 167–173)
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Introduction
Rho-kinase has been identiﬁed as one of the
eﬀectors of the small GTP-binding protein, Rho.
Previous studies have demonstrated that the Rho/
Rho-kinase mediated pathway was involved in
various cardiovascular responses under pathophysio-
logical conditions.1) Some reports have indicated the
important contribution of Rho signaling in the
regulation of AV conduction and sinus node func-
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tion.2–4) Furthermore, Wei et al. suggested the
possibility of proarrhythmic eﬀects of disruption of
the Rho pathway.4) However, the relationships
between Rho/Rho-kinase signaling and the electro-
physiological characteristics of the atrium have not
been well discussed. Therefore, we investigated the
contribution of the Rho/Rho-kinase pathway on
changes of the atrial electrical characteristics related
to rapid pacing in a canine model.
Methods
Animal preparation
The protocol was approved by the ethical com-
mittees of the Kanazawa University School of
Medicine and was performed in accordance with
institutional guidelines. Animals used in this study
received humane care in compliance with the
‘‘Principles of Laboratory Animal Care’’, formulated
by the National Society for Medical Research, and
the ‘‘Guide for the Care and Use of Laboratory
Animals’’, prepared by the Institute of Laboratory
Animal Resources and published by the National
Institutes of Health (NIH Publication 85-23, revised
1996).
Seventeen adult mongrel dogs weighing 12 to 20
kg were utilized in these experiments. The animals
were anesthetized with sodium pentobarbital (25
mg/kg i.v., followed by bolus doses of 4mg/kg as
needed). Artiﬁcial respiration was maintained via an
endotracheal tube connected to a Harvard mechan-
ical ventilator (Harvard Apparatus, Holliston MA).
The chest was opened through the left ﬁfth inter-
costal space. Two bipolar electrodes (interelectrode
distance, 1.5mm) were sutured to the right atrial
appendage (RAA), and left atrium (LA) just beside
the left pulmonary veins for electrophysiological
study. Another electrode of the same type was
sutured to the left atrial appendage (LAA) for rapid
atrial pacing. A unipolar epicardial pacing lead
(OSCAR MEDICAL, Tokyo, Japan) was sutured to
the right ventricle, connected to a programmable
VVI pacemaker (Pacesetter, St. Jude Medical, St.
Paul, MN, USA) and was placed in a subcutaneous
pocket.5) Complete atrioventricular block was cre-
ated by radiofrequency ablation, and VVI pacing
was initiated at 80 pulses per minute. Upon
completion of surgery, the dogs were administered
antibiotics and allowed to recover.
Experimental preparation
After 1 to 2 weeks from the operation and with
conformation of the physical recovery of the dogs,
re-anesthesia and ventilation were performed in
the same manner. Arterial blood pressure (RM-
7000, NIHON KODEN, Tokyo, Japan) and arterial
blood oxygen concentration were continuously
monitored (ABL-5, Radiometer, Copenhagen, Den-
mark) throughout the protocols. The respiratory
parameters were adjusted to maintain arterial blood
gases at physiological levels (SaO2 > 92%; pH 7.35
to 7.45). An electric blanket was utilized to maintain
the body temperature at 37 1 C. Pharmacological
autonomic blockade was achieved by i.v. bolus
injections of atropine (0.04mg/kg) and propranolol
(0.2mg/kg), followed by a continuous infusion
throughout the experiment (0.007 and 0.04mg/
kg/h, respectively). Thirty minutes after the initial
infusion of atropine and propranolol, and stability
of the heart rate and the blood pressure were
conﬁrmed, infusion of saline or experimental drugs
was started.
Electrophysiological study
A cardiac stimulator (BC-02A, Fukuda Denshi,
Tokyo, Japan) was utilized to deliver square-wave
impulses of 1ms duration. The surface ECG (lead II)
and intracardiac electrograms were continuously
monitored and recorded (Mingograph 7, Siemens-
Elema AB, Solna, Sweden). Thirty minutes after
initiation of experimental drug infusion, the AERP
of the RAA and LA were measured at a basic cycle
length (BCL) of 350 and 250ms as baseline data.
Seven basic drive stimuli were followed by a single
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Figure 1 Typical recordings of electrocar-
diograms (lead II) and intracardiac electro-
grams at baseline (left) and during atrial
extrastimuli (right).
At baseline, ventricular pacing at 80 bpm with
complete atrio-ventricular block was shown.
The interval between the atrial electrograms
was 360ms. Extrastimuli at the RAA with basic
cycle length 250ms and S1–S2 interval 190ms
were followed by the excitation. RAA indicates
right atrial appendage, and LAA left atrial
appendage.
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premature stimulus, and all stimuli were twice the
diastolic voltage threshold (Figure 1). The interval
between S1 and S2 was decreased in steps of 5ms,
and the AERP was deﬁned as the longest S1–S2
coupling interval that failed to result in a propagated
atrial response. After determination of the baseline
AERP, high-frequency atrial pacing at 500 bpm from
the electrode at the LAA was initiated (3 times the
diastolic voltage threshold) and maintained for 6
hours. The LAA was chosen as the rapid atrial
pacing site in order to invoke the local excitations
more steadily, for AERP of the LAA was rather short
among most atrial sites. Rapid atrial pacing was
interrupted brieﬂy at 1, 3, and 6 hours to allow for
repeated assessment of the AERP. AERP measure-
ments were made every 15 minutes for 30 minutes
after the cessation of rapid pacing.
Infusion of drugs
Infusion of the Rho/Rho-kinase inhibitor fasudil
(n ¼ 7), verapamil (n ¼ 5), or saline as control (n ¼
5) was initiated 30 minutes before baseline measure-
ments and maintained until the completion of the
protocol. Fasudil was administered at a dose of
1mg/kg for the ﬁrst 3 minutes, followed by a
continuous infusion of 15 mg/kg/min. This was a
similar dosage to that used in previous reports, and
did not alter the hemodynamic parameters.6,7) Vera-
pamil administration was initiated with a loading
dose of 0.1mg/kg for the ﬁrst 2 minutes, followed
by a continuous infusion of 5 mg/kg/min. The drug
and control experiments were performed in a
randomized manner.
Statistical analysis
All values were expressed as the mean SD.
Continuous values were compared with paired t test.
ANOVA with Dunnett’s test was utilized to evaluate
the diﬀerences between groups. A two-sided prob-
ability level of p < 0:05 was considered to indicate
statistical signiﬁcance.
Results
Control condition
The absolute value of AERP at the LA was shorter
compared with that at the RAA (115 13ms versus
126 20ms at a BCL of 350ms, p ¼ 0:01; 110
13ms versus 119 17ms at a BCL of 250ms, p ¼
0:05) even after administration of autonomic block-
ade (Table 1). The shortening of the AERP began in
the ﬁrst hour and remained consistent throughout the
subsequent ﬁve hours of rapid pacing. The AERPs at
the RAA after 6 hours of pacing were 26 7ms
Table 1 Changes in mean AERPs before, during, and after rapid atrial pacing.
Time, min
0 60 180 360 15 SR 30 SR
RAA
BCL 250 ms
Control 119 17 110 12 104 13 101 14y 115 12 117 14
Fasudil 136 15 130 18 126 17y 126 20 138 17 139 19
Verapamil 136 10 130 12 134 15 134 21 135 5 135 5
BCL 350 ms
Control 126 20 111 16y 103 14y 100 14 119 13 121 14
Fasudil 146 17 135 20y 131 16y 131 23 146 19 146 19
Verapamil 144 12 138 16 135 15 138 20 144 10 146 11
LA
BCL 250 ms
Control 110 13 98 12y 92 12y 90 13y 97 14y 102 12
Fasudil 110 16 106 18 107 15 109 19 109 18 110 15
Verapamil 109 10 111 15 110 10 101 14 103 16 106 14
BCL 350 ms
Control 115 13 104 14y 95 13y 92 14y 98 16 101 12y
Fasudil 116 19 111 14 113 17 112 21 114 22 115 21
Verapamil 117 8 114 15 112 12 105 15 108 19 109 16
Values are given as mean SD. yP < 0:01, P < 0:05 compared with baseline (time 0). SR (= sinus rhythm) indicates time
after oﬀset of rapid pacing. AERP = atrial eﬀective refractory period; BCL = basic cycle length; RAA = right atrial
appendage; LA = left atrium
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Figure 2 Time course of atrial eﬀective refractory period (AERP) changes produced by rapid atrial pacing at the right atrial
appendage (RAA) and left atrium (LA) in the control group (n ¼ 5).
The baseline AERP at the LA tended to be shorter than that at the RAA at basic cycle lengths (BCLs) of 350 and 250ms. The AERP was
attenuated during rapid pacing at both BCLs, and the AERP diﬀerences from BCLs gradually tended to be smaller during rapid pacing.
After cessation of rapid pacing, the AERP at the RAA was restored to the baseline within 30 minutes, but the recovery of the AERP was
slower at the LA at both BCLs. SR indicates the time after oﬀset of rapid pacing.
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Figure 3 Time course of atrial eﬀective refractory period (AERP) changes produced by atrial pacing during infusion of fasudil,
verapamil, or saline at the right atrial appendage (RAA) and left atrium (LA) at the BCL of 350ms.
During infusion of verapamil, the AERP did not shorten during rapid atrial pacing at the RAA and the LA. During infusion of fasudil, the
AERP was slightly attenuated at the RAA but not at the LA. The AERP shortening at the RAA by the high-frequency pacing was
signiﬁcantly reduced in the fasudil group compared to the control. SR indicates the time after oﬀset of rapid pacing.
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(20 4%) and 18 8ms (15 7%); less than the
baseline at BCLs of 350 (p < 0:05) and 250ms (p <
0:01), respectively. At the LA, the mean AERPs
after 6 hours of pacing were 23 6ms (20 5%)
and 20 4ms (18 3%); less than baseline at BCLs
of 350 (p < 0:01) and 250ms (p < 0:01), respec-
tively. After the cessation of rapid pacing, AERPs at
the RAA were almost recovered to baseline within
30 minutes (3 7 and 1 5% versus baseline at
BCLs of 350 and 250ms, respectively), but the
recovery of AERPs was slower at the LA (12 5
and 7 5% versus baseline at BCLs of 350 and
250ms, respectively) (Figure 2).
Administration of verapamil or fasudil
The AERP remained unchanged during rapid
atrial pacing after the infusion of verapamil (Table 1).
During infusion of fasudil, the AERP at the LA also
remained unchanged throughout rapid atrial pacing.
Furthermore, the shortening of AERP at the RAA
tended to be smaller after administration of fasudil
compared with control conditions (15 14 and
10 10ms versus baseline at BCLs of 350 (p <
0:05) and 250ms (p < 0:05), respectively) (Table 1,
Figure 3).
Only LA extra-stimuli induced short duration
atrial ﬁbrillation in several dogs. Furthermore,
fasudil and verapamil did not interfere with this
induction ability. None of the dogs exhibited
induction of atrial ﬁbrillation by RA extra-stimuli
(data not shown).
In response to the initial bolus intravenous
injection of verapamil or fasudil, the arterial pressure
tended to be slightly attenuated, but this change was
not statistically signiﬁcant (from 154 44/80 21
to 152 42/81 16mmHg with verapamil, and
from 163 46/87 18 to 137 29/67 9mmHg
with fasudil, respectively). There were no signiﬁcant
changes during continuous infusion throughout the
experiments.
Discussion
The major ﬁndings of this study are as follows: (1)
the AERP was signiﬁcantly shortened during rapid
atrial pacing in this closed-chest dog model at
the left atrium and right atrial appendage, and (2)
the change of the AERP during rapid pacing was
abrogated by continuous administration of the Rho/
Rho-kinase inhibitor, fasudil, especially in the LA, in
a manner similar to the infusion of verapamil. Thus,
these ﬁndings are the ﬁrst to demonstrate that rapid
pacing-induced atrial electrophysiological changes
involve the Rho/Rho-kinase systems.
Experimental and clinical studies have demon-
strated a progressive shortening of atrial refractori-
ness in response to rapid atrial pacing, and this
phenomenon is deﬁned as ‘‘atrial electrical remodel-
ing’’.8,9) The shortening of the AERP induced by
short-term rapid atrial pacing has been shown to be
blocked by the L-type calcium channel blocker,
verapamil, and is accentuated by hypercalcaemia.8)
The autonomic responses, atrial mechanical stretch
and depletion of high-energy phosphates have been
reported to exert very limited inﬂuence on AERP
shortening.8) Therefore, calcium loading might be
responsible for this type of atrial electrophysiolog-
ical change. Our data, under control conditions
demonstrated AERP shortening by an average of 18
to 26ms from the baseline after 6 hours of rapid
pacing. This electrophysiological change was abro-
gated by verapamil, which was quite similar to
previous reports.8) However, the intracellular signal-
ing pathway responsible for the changes in the AERP
after the calcium inﬂux into the cell remains to be
elucidated.
Several studies have demonstrated regional diﬀer-
ence of AERP.9,10) We observed 9 to 30ms dif-
ferences of the AERP between the RAA and LA at
the baselines. Furthermore, in our study the recovery
of the AERP at the LA after cessation of the rapid
pacing was signiﬁcantly slower, compared with that
at the RAA, similar to the ﬁndings of previous
studies.9)
The low-molecular-weight G protein, Rho, is a
member of the Rho family of small GTPases, which
also includes Rac and Cdc42. These GTPases act as
molecular switches to regulate cellular function.11)
The role of the Rho/Rho-kinase pathway has been
discussed mainly in smooth muscle, regulating
myosin light chain (MLC2) phosphorylation, and
has been reported to be an important factor espe-
cially in hypertension or coronary vasospasm.12,13)
Furthermore, Rho-kinase has been recognized to
promote hypertrophic changes and ﬁbrosis in cardiac
cells.13–17) By contrast, the interaction between the
Rho/Rho-kinase signal and atrial muscle contrac-
tility has been demonstrated in rats and humans.18,19)
The Rho/Rho-kinase pathway has also been dem-
onstrated to play an important role in regulating the
development of the cardiac conduction system.2–4)
Wei et al. reported that inhibition of Rho family
protein activities stimulated atrioventricular conduc-
tion abnormalities with prolonged atrial refractory
periods and suggested the possible contribution of
Rho signals towards atrial arrhythmias.2)
According to the current ﬁndings with fasudil, the
shorting of the AERP after rapid atrial pacing was
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partially but signiﬁcantly reduced by inhibition of
the Rho/Rho-kinase pathway. The direct interaction
of the Rho/Rho-kinase system and calcium kinetics
has only been demonstrated in vitro. In general, the
eﬀect(s) of the Rho/Rho-kinase pathway on smooth
muscle contraction has been considered to occur
via a calcium-independent pathway. However, Rho-
kinase inhibitors have been shown to reduce the
noradrenaline-evoked stimulation of calcium inﬂux,
distinct from voltage-operated calcium channels or
thapsigargin-activated store-operated channels in
vascular smooth muscle.20) In addition, the species-
speciﬁc cross-interaction of Rho-kinase with L-type
calcium channel activation has recently been sug-
gested. In brief, the Rho-kinase inhibitor directly
inhibited smooth muscle contraction through inter-
ference with L-type calcium channel inactivation in
rat ureter smooth muscle.21) Furthermore, tracheal
smooth muscle contraction was mediated through the
Rho-kinase pathway via increased calcium inﬂux
and augmented calcium sensitization.22) Thus, the
interactions between calcium kinetics and the Rho/
Rho-kinase pathway may be diﬀerent between
organs and under various pathophysiological con-
ditions. In this study, the eﬀects of fasudil and
verapamil showed some tendency to diﬀer between
the atria. A certain signaling pathway accompanied
with these drugs aﬀecting the AERP changes by
rapid atrial pacing might be diﬀerent between the
atria. The changes of the AERP throughout rapid
pacing after administration of verapamil and fasudil
were similar throughout this investigation, at least in
the LA. These electrophysiological characteristics
might be inﬂuenced by mechanical stress, in addition
to electrical stress. However, we only performed
provocation for 6 hours and administered artiﬁcial
atrio-ventricular block to exclude the eﬀect of
documented hemodynamic changes, such as cardiac
dysfunction.8) None of the dogs exhibited any
signiﬁcant changes of systemic blood pressure, nor
showed apparent tachy- or bradycardia throughout
this investigation. We carefully conducted this
experiment to avoid with the eﬀects of physiological
and other types of stress.
In summary, the atrial electrical remodeling
evoked by 6 hours of rapid atrial pacing was
initiated by intracellular calcium overload. The
Rho-kinase inhibitor, fasudil, reduced the changes
in AERP throughout rapid atrial pacing. Based on
these ﬁndings, the Rho/Rho-kinase system is sig-
niﬁcantly involved in the pacing-induced shortening
of the atrial eﬀective refractory period in a canine
model.
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